Kopitar Z, Vrhovac B, Povsic L, Plavsić F, Francetić I, Urbancic J
Research and Development Department, LEK Pharmaceuticals, Ljubljana, Yugoslavia.
Eur J Drug Metab Pharmacokinet. 1991 Jul-Sep;16(3):177-81. doi: 10.1007/BF03189956.
The effect of food and metoclopramide on the pharmacokinetics of bromocriptine was investigated in 7 healthy subjects. Plasma concentrations of bromocriptine were measured by radioimmunoassay after a single oral dose of 7.5 mg bromocriptine. Maximal plasma concentrations of bromocriptine were slightly lower when the drug was given after breakfast. Bioavailability of the drug was not significantly reduced by food nor by metoclopramide pre-treatment. Side effects of bromocriptine were considerably reduced by metoclopramide pre-treatment (0.5 mg/kg); the decrease was about 83% as estimated from Table II.
在7名健康受试者中研究了食物和甲氧氯普胺对溴隐亭药代动力学的影响。单次口服7.5mg溴隐亭后,通过放射免疫分析法测定血浆中溴隐亭的浓度。早餐后服用该药时,溴隐亭的最大血浆浓度略低。食物和甲氧氯普胺预处理均未显著降低该药的生物利用度。甲氧氯普胺预处理(0.5mg/kg)可显著降低溴隐亭的副作用;根据表II估计,降低幅度约为83%。